Hypoxia- and radiation-induced overexpression of Smac by an adenoviral vector and its effects on cell cycle and apoptosis in MDA-MB-231 human breast cancer cells

Experimental and Therapeutic Medicine

Volumn 6, Issue 6, 2013, Pages 1560-1564

  Liu, Wei Wu ^a,b   Liu, Yang ^a   Liang, Shuo ^a   Wu, Jia Hui ^a   Wang, Zhi Cheng ^a   Gong, Shou Liang ^a  

^a Center for Radiological Research   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Apoptosis; Breast cancer; Hypoxia; Radiation; Second mitochondria derived activator of caspase

Indexed keywords

ADENOVIRUS VECTOR; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; NEOPLASM; PROTEIN EXPRESSION; WESTERN BLOTTING; X IRRADIATION;

EID: 84888395596     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.1351     Document Type: Article

References (27)

1. DeSantis C, Siegel R, Bandi P and Jemal A: Breast cancer statistics, 2011. CA Cancer J Clin 61: 409-418, 2011.
2. Kwong DL, Sham JS, Leung LH, Cheng AC, Ng WM, Kwong PW, Lui WM, Yau CC, Wu PM, Wei W and Au G: Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 64: 374-381, 2006.
3. Zheng AQ, Song XR, Yu JM, Wei L, and Wang XW: Liposome transfected to plasmid-encoding endostatin gene combined with radiotherapy inhibits liver cancer growth in nude mice. World J Gastroenterol 11: 4439-4442, 2005.
4. Harari PM and Huang SM: Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. Int J Radiat Oncol Biol Phys 49: 427-433, 2001.
5. Liu LL, Smith MJ, Sun BS, Wang GJ, Redmond HP and Wang JH: Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model. Ann Surg Oncol 16: 1403-1411, 2009.
6. Yang W and Li XY: Anti-tumor effect of pEgr-interferon-γ-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism. Chin Med J (Engl) 118: 296-301, 2005.
7. Li Y, Guo C, Wang Z, Gong P, Sun Z and Gong S: Enhanced effects of TRAIL-endostatin-based double-gene-radiotherapy on suppressing growth, promoting apoptosis and inducing cell cycle arrest in vascular endothelial cells. J Huazhong Univ Sci Technolog Med Sci 32: 167-172, 2012.
8. Wu C, Li X and Tian M: Effect of pEgr-TNFalpha gene radiotherapy on mice melanoma. Melanoma Res 15: 185-190, 2005.
9. Zhang Y, Yu XH, Zha X and Kong W: Adenovirus-mediated HSV-TK gene therapy using hTERT promoter in CNE cells in vitro. Chem Res Chinese Universities 25: 60-63, 2009.
10. Wang WD, Chen ZT, Li DZ, Duan YZ, Wang ZX and Cao ZH: HSV-TK gene therapy of lung adenocarcinoma xenografts using a hypoxia/radiation dual-sensitive promoter. Ai Zheng 23: 788-793, 2004 (In Chinese).
11. Mizutani Y, Nakanishi H, Yamamoto K, Li YN, Matsubara H, Mikami K, Okihara K, Kawauchi A, Bonavida B and Miki T: Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance. J Clin Oncol 23: 448-454, 2005.
12. Pluta P, Cebula-Obrzut B, Ehemann V, Pluta A, Wierzbowska A, Piekarski J, Bilski A, Nejc D, Kordek R, Robak T, Smolewski P and Jeziorski A: Correlation of Smac/DIABLO protein expression with the clinico-pathological features of breast cancer patients. Neoplasma 58: 430-435, 2011.
13. Fulda S, Wick W, Weller M and Debatin KM: Smac agonists sensitize for Apo2L/TRAIL or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8: 808-815, 2002.
14. Lok CN and Ponka P: Identification of a hypoxia response element in the transferin receptor gene. J Biol Chem 274: 24147-24152, 1999.
15. Okino ST, Chichester CH and Whitlock JP Jr: Hypoxia-inducible mammalian gene expression analyzed in vivo at a TATA-driven promoter and at an initiator-driven promoter. J Biol Chem 273: 23837-23843, 1998.
16. Kwon OJ, Kim PH, Huyn S, Wu L, Kim M and Yun CO: A hypoxia-and α-fetoprotein-dependent oncolytic adenovirus exhibits specific killing of hepatocellular carcinomas. Clin Cancer Res 16: 6071-6082, 2010.
17. Barnes MN, Coolidge CJ, Hemminki A, Alvarez RD and Curiel DT: Conditionally replicative adenoviruses for ovarian cancer therapy. Mol Cancer Ther 1: 435-439, 2002.
18. Wu JH, Wang HF, Wang ZC, Xu K, Qi YL, Li JH, Gong SL, Liu Y and Liu Y: Conditionally replicating adenovirus combined with gene-targeted radiotherapy induces apoptosis via TRAIL death receptors in MDA-MB-231 cells. Mol Med Rep 8: 299-305, 2013.
19. 2 in cultured cancer cells. J Pineal Res 44: 121-126, 2008.
20. Liu G, Gong P, Zhao H, Wang Z, Gong S and Cai L: Effect of low-level radiation on the death of male germ cells. Radiat Res 165: 379-389, 2006.
21. Yang SW, Chanda D, Coody JJ, Rivera AA, Waehler R, Siegal GP, Douglas JT and Ponnazhagan S: Conditionally replicating adenovirus expressing TIMP2 in creases survival in a mouse model of disseminated ovarian cancer. PLoS One 6: e25131, 2011.
22. Zheng FQ, Xu Y, Yang RJ, Wu B, Tan XH, Qin YD and Zhang QW: Combination effect of oncolytic adenovirus therapy and herpes simplex virus thymidine kinase/ganciclovir in hepatic carcinoma animal models. Acta Pharmacol Sin 30: 617-627, 2009.
23. Senzer N, Mani S, Rosemurgy A, Nemunaitis J, Cunningham C, Guha C, Bayol N, Gillen M, Chu K, Rasmussen C, Rasmussen H, Kufe D, Weichselbaum R and Hanna N: TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. J Clin Oncol 22: 592-601, 2004.
24. Kasuya H, Takeda S, Nomoto S and Nakao A: The potential of oncolytic virus therapy for pancreatic cancer. Cancer Gene Ther 12: 725-736, 2005.
25. Teyssier F, Bay JO, Dionet C and Verrelle P: Cell cycle regulation after exposure to ionizing radiation. Bull Cancer 86: 345-357, 1999 (In French).
26. Deplanque G, Céraline J, Mah-Becherel MC, Cazenave JP, Bergerat JP and Klein-Soyer C: Caffeine and the G2/M block override: a concept resulting from a misleading cell kinetic delay, independent of functional p53. Int J Cancer 94: 363-369, 2001.
27. Guo C, Li Y, Zhang H, Wang Z, Jin M, Zhang L, An L, Hu G, Liu X, Liu Y, Du H and Sun Z: Enhancement of antiproliferative and proapoptotic effects of cadmium chloride combined with hSmac in hepatocellular carcinoma cells. Chemotherapy 57: 27-34, 2011.